A novel antibody targeting TIM-3 resulting in receptor internalization for cancer immunotherapy

BACKGROUND: Strategies to reinvigorate exhausted T cells have achieved great efficacy in certain subpopulations of tumor patients. Blocking the antibodies that target programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 induces durable responses in Hodgkin’s lymphom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuang, Zhihui, Li, Li, Zhang, Pan, Chen, Bingliang, Wu, Min, Ni, Haiqing, Yi, Shuai, Zou, Jia, Liu, Junjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990255/
https://www.ncbi.nlm.nih.gov/pubmed/33928230
http://dx.doi.org/10.1093/abt/tbaa022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990255/
https://www.ncbi.nlm.nih.gov/pubmed/33928230
http://dx.doi.org/10.1093/abt/tbaa022

Ejemplares similares